Vimian Group AB (publ) (OTCMKTS:VIMGF – Get Free Report) and Olink Holding AB (publ) (NASDAQ:OLK – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, dividends and valuation.
Profitability
This table compares Vimian Group AB (publ) and Olink Holding AB (publ)’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Vimian Group AB (publ) | N/A | N/A | N/A |
| Olink Holding AB (publ) | -12.34% | -4.12% | -3.61% |
Institutional & Insider Ownership
32.5% of Olink Holding AB (publ) shares are held by institutional investors. 5.2% of Olink Holding AB (publ) shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Valuation & Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Vimian Group AB (publ) | N/A | N/A | N/A | N/A | N/A |
| Olink Holding AB (publ) | $139.85 million | 14.02 | -$12.85 million | ($0.14) | -113.92 |
Vimian Group AB (publ) has higher earnings, but lower revenue than Olink Holding AB (publ).
Analyst Ratings
This is a breakdown of recent ratings and target prices for Vimian Group AB (publ) and Olink Holding AB (publ), as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Vimian Group AB (publ) | 0 | 1 | 1 | 0 | 2.50 |
| Olink Holding AB (publ) | 0 | 2 | 3 | 0 | 2.60 |
Olink Holding AB (publ) has a consensus price target of $23.60, suggesting a potential upside of 47.96%. Given Olink Holding AB (publ)’s stronger consensus rating and higher possible upside, analysts clearly believe Olink Holding AB (publ) is more favorable than Vimian Group AB (publ).
Summary
Olink Holding AB (publ) beats Vimian Group AB (publ) on 6 of the 9 factors compared between the two stocks.
About Vimian Group AB (publ)
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.
About Olink Holding AB (publ)
-logo.png?v=20221121151525){kind=logo}
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. In addition, the company provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden. Olink Holding AB (publ) is a subsidiary of Summa Equity Holding AB.
Receive News & Ratings for Vimian Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vimian Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
